Markets:

Overview

News

Currencies

International

Treasuries

HealthEquity, Inc. - Common Stock (NQ:HQY)

85.60 +1.32 (+1.57%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about HealthEquity, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Expert Outlook: HealthEquity Through The Eyes Of 8 Analysts ↗

April 11, 2025

Via Benzinga

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY

April 07, 2025

From Pomerantz LLP

Via GlobeNewswire

HealthEquity, Inc. Announcement: If You Have Suffered Losses in HealthEquity, Inc. (NASDAQ: HQY) You Are Encouraged to Contact The Rosen Law Firm About Your Rights

April 06, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY

April 03, 2025

From Pomerantz LLP

Via GlobeNewswire

Rosen Law Firm Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation – HQY

April 02, 2025

From The Rosen Law Firm, P.A.

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY

March 30, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY

March 26, 2025

From Pomerantz LLP

Via GlobeNewswire

HealthEquity Earns Stock Upgrade Despite Fraud Concerns ↗

March 25, 2025

HealthEquity's Q4 revenue beat estimates, but EPS missed. Raymond James upgraded the stock to Strong Buy, citing long-term growth despite fraud concerns.

Via Benzinga

Topics Fraud

Avalo Therapeutics 'Represents An Attractive Pure-Play,' Analyst Initiates Coverage With Over 300% Stock Upside ↗

March 25, 2025

Avalo Therapeutics' AVTX-009 is advancing in hidradenitis suppurativa, with Phase 2 data expected in 2026. Stifel initiates coverage with a $36 price target.

Via Benzinga

This Cloudflare Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗

March 25, 2025

Via Benzinga

$1000 Invested In HealthEquity 10 Years Ago Would Be Worth This Much Today ↗

March 24, 2025

Via Benzinga

Why HealthEquity Stock Was Sliding This Week ↗

March 20, 2025

Via The Motley Fool

HealthEquity Stock Sees Biggest Drop In Over 3 Years On Disappointing Outlook — Retail Doesn't Feel It's All Doom And Gloom ↗

March 20, 2025

CFO James Lucania said on the earnings call that fraud prevention efforts are ongoing, and service expenses are expected to remain elevated through the first half of fiscal 2026.

Via Stocktwits

Topics Earnings Fraud

4 Analysts Assess HealthEquity: What You Need To Know ↗

March 19, 2025

Via Benzinga

HealthEquity's Long-Term Growth Intact Despite Short-Term Margin Pressures, Analyst Says ↗

March 19, 2025

HealthEquity reported 19% revenue growth but missed Q4 EPS estimates. Analysts see earnings improving as cybersecurity costs ease and HSA growth continues.

Via Benzinga

Dow, Nasdaq Rally Ahead Of Interest Rate Decision ↗

March 19, 2025

Stocks are rallying ahead of the Federal Reserve's interest rate decision, due out later this afternoon.

Via Talk Markets

Topics Economy Stocks Stocks / Equities

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 19, 2025

Via Benzinga

Wednesday's session: gap up and gap down stocks ↗

March 19, 2025

Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session.

Via Chartmill

Dow Surges Over 200 Points; US Crude Oil Inventories Increase More than Expected ↗

March 19, 2025

Via Benzinga

Topics Stocks

Discover the top movers in Wednesday's pre-market session. ↗

March 19, 2025

Wondering what's happening in Wednesday's pre-market session? Find an overview in this article.

Via Chartmill

Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

March 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 19, 2025

Via Benzinga

US Stocks Likely To Open Higher Ahead Of FOMC Decision: 'Tariffs Remain The Dominant Market Force' Amid Rising Economic Uncertainty, Says Expert ↗

March 19, 2025

U.S. stock futures advanced on Wednesday ahead of the Federal Open Market Committee's decision on the interest rates.

Via Benzinga

Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket ↗

March 19, 2025

Via Benzinga

Williams-Sonoma, HealthEquity And 3 Stocks To Watch Heading Into Wednesday ↗

March 19, 2025

Via Benzinga

Which stocks are moving after the closing bell on Tuesday? ↗

March 18, 2025

Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

HealthEquity Stock Falls After Reporting Q4 Results: Revenue Beat, EPS Miss, Soft Guidance ↗

March 18, 2025

HealthEquity reports fourth-quarter financial results after the market close on Tuesday and shares are sinking. Here's a rundown of the report.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 18, 2025

Via Benzinga

US Futures Show Caution Among Investors Ahead Of FOMC Meeting: Analysts Say Only Certainty Is That 'Things Will Remain Uncertain For The Time Being' ↗

March 18, 2025

U.S. stock futures were flat on Tuesday after a bounce back on Monday. Futures of all four benchmark indices were mixed in premarket trading.

Via Benzinga

Earnings Scheduled For March 18, 2025 ↗

March 18, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.